The importance of bacterial superantigens produced by Staphylococcus aureus in the treatment of atopic dermatitis using povidone-iodine

Dermatology

Volumn 212, Issue SUPPL. 1, 2006, Pages 26-34

  Sugimoto, Kazuo ^a,b   Ishikawa, Nobuyasu ^a   Terano, Takashi ^a   Kitukawa, Yoshio ^a   Kubosawa, Hitoshi ^b   Ito, Shoichi ^c   Hattori, Takamichi ^c  

^a Department of Clinical Allergology ^*  (Japan)

^b CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antitoxin IgE antibody; Atopic dermatitis; Bacterial superantigen; Disinfection therapy; Povidone iodine

Indexed keywords

ANTITOXIN; BACTERIAL TOXIN; IMMUNOGLOBULIN E; POVIDONE IODINE; SUPERANTIGEN; TOPICAL ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ATOPIC DERMATITIS; CERVICAL SPINE; CHILD; DUODENITIS; FEMALE; HUMAN; IMMUNOLOGY; MALE; SPINAL CORD DISEASE; SPINE DISEASE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; ANTITOXINS; BACTERIAL TOXINS; CERVICAL VERTEBRAE; CHILD; DERMATITIS, ATOPIC; DRUG RESISTANCE, BACTERIAL; DUODENITIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; POVIDONE-IODINE; SPINAL CORD DISEASES; SPINAL DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TREATMENT OUTCOME;

EID: 33745235572     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000089196     Document Type: Conference Paper

References (21)

1. Sugimoto K, Kuroki H, Kanazawa M, Kurosaki T, Abe H, Takahashi Y, Ishiwada N, Nezu Y, Hoshioka A, Toba T: New successful treatment with disinfectant for atopic dermatitis. Dermatology 1997; 195(suppl 2):62-68.
2. Sugimoto K, Ishikawa N, Sugioka T, et al: The importance of disinfection therapy using povidone-iodine solution in atopic dermatitis. Dermatology 2002; 204(suppl 1):63-69.
3. Ito S, Hattori T, Fukutake T, Sugimoto K: Is atopic dermatitis a risk factor for intervertebral disc degeneration? A preliminary clinical and MRI study. J Neurol Sci 2003; 206: 39-42.
4. Sugimoto K, Ishikawa, Terano T, Kitsukawa Y, Kubosawa H, Ito S, Hattori T: The importance of bacterial superantigens produced from Staphylococcus aureus in atopic dermatitis. Japan Hifu no Kagaku 2004; 3(suppl 4):86-92.
5. Yamada H, Izutani R, Chihara J, Yudate T, Matsukura M, Tezuka T: RANTES mRNA expression in skin and colon of patients with atopic dermatitis. Int Arch Allergy Immunol 1996; 111(suppl 1):19-21.
6. Kira J, Yamasaki K, Kawano Y, Kobayashi T: Acute myelitis associated hyperIgEemia and atopic dermatitis. Neurol Sci 1997; 148: 199-203.
7. Sugimoto K, Ishikawa N, Sugioka Y, Nakamura M, Koneki H, Nakano M, Kagawa S, Katou H: Isojin disinfectant therapy for atopic dermatitis. Jpn J Pediatr Dermatol 1998; 17: 103-107.
8. Sugimoto K: Atopic dermatitis and Staphylococcus aureus. Jpn J Pediatr Med 2000; 32: 1062-1065.
9. Bunikowski R, Mielke M, Skarabis H, Herz U, Bergmann R, Wahn U, Renz H: Prevalence and role of serum IgE antibodies to the Staphylococcus aureus -derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999; 103: 119-124.
10. Nomura I, Tanaka K, Tomita H, Katsunuma T, Ohya Y, Ikeda N, Saito H, Akasawa A: Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999; 104: 441-446.
11. Tada J, Toi Y, Akiyama H, Arata J, Kato H: Presence of specific IgE antibodies to staphylococcal enterotoxins in patients with atopic dermatitis. Eur J Dermatol 1996; 6: 552-554.
12. Bunikowski R, Mielke MEA, Sakarabis H, Worm M, Anagnostopoulos I, Kolde G, Wahn U, Renz H: Evidence for a disease-promoting effect of Staphylococcus aureus -derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000; 105: 814-819.
13. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P: The Vbeta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal detection in neonatal mice. Cell 1989; 56: 17-35.
14. Uchiyama T, Yan XJ, Imanishi K, Yagi L: Bacterial superantigens - Mechanisms of T cell activation by the superantigens and their role in the pathogenesis of infectious disease. Microbiol Immunol 1994; 38: 245-256.
15. Saloga J, Knop J: Superantigens in the skin diseases. Eur J Dermatol 1999; 9: 586-591.
16. Strange P, Skov L, Lisby S, Niesen PL, Baadsgaard O: Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996; 132: 27-33.
17. Akiyama H, Toi Y, Kanzaki JH, Tada J, Arata J: Prevalence of producers of enterotoxins and toxic shock syndrome toxin 1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions. Acta Dermatol Res 1996; 288: 418-420
18. Leung DY, Harbeck R, Bina P, Reiser R, Yang E, Norris D, Hanidin JM, Sampson HA: Presence of IgE antibodies to staphylococcal exotoxin on the skin of patients with atopic dermatitis. J Clin Invest 1993; 92: 1374-1380.
19. Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DYM: Application of staphylococcal enterotoxin B on normal and atopic skin induced up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000; 105: 820-826.
20. Zollner TM, Wichelhaus TA, Hartung A, Von Mllinckrodt C, Wagner TO, Brade V, Kaufmann R: Colonization with superantigenproducing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000; 30: 994-1000.
21. Nissen D, Pedersen LJ, Skov PS, Vejlsgaard GL, Poulsen LK, Jarlov JO, Karlsmark T, Nolte H: IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol 1997; 79: 403-408.